I assume financial health of RCE is biggest contrain on RCE sp. We need funds and the present management looks inexperienced on that front.
May be a collaboration or partnership is required here.
dyor
Ann: Phase II ABSSSI Clinical Trial Advances to Final Stages, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.015(4.05%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.227K | 3.229K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14658 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 20000 | 2 |
View Market Depth
| Last trade - 12.40pm 07/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |